Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.
Leukemia
; 34(10): 2820, 2020 Oct.
Article
in En
| MEDLINE
| ID: mdl-32733013
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Risk_factors_studies
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: